Roger D. Weiss

Also affiliated with Harvard University, School of the Art Institute of Chicago, Massachusetts Mental Health Center, McLean Hospital, Fenway Health

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

0.978Author DataRank

Indexed papers

4in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The opioid use disorder core outcomes set (OUD–COS) for treatment research: findings from a Delphi consensus study

Addiction(2022)10.1111/add.15875

Top 21%

0.978DataRank

Top 21%23 citations

John Marsden, Connor McCluskey, Randy A. Boley, Katharine A. Bradley, Cynthia I. Campbell +18 more

Papers

Driven by 26 papers — median percentile 79. Top paper: “The opioid use disorder core outcomes set (OUD–COS) for treatment research: findings from a Delphi consensus study”.

The opioid use disorder core outcomes set (OUD–COS) for treatment research: findings from a Delphi consensus study

Addiction(2022)10.1111/add.15875

Top 21%

0.978DataRank

Top 21%23 citations

John Marsden, Connor McCluskey, Randy A. Boley, Katharine A. Bradley, Cynthia I. Campbell +18 more

Impact of cannabidiol on reward- and stress-related neurocognitive processes among individuals with opioid use disorder: A pilot, double-blind, placebo-controlled, randomized cross-over trial

Frontiers in Psychiatry(2023)10.3389/fpsyt.2023.1155984

N/A

0.565DataRank · unranked

13 citations

Sara Prostko, Veronica Szpak, Peter R. Chai, Primavera A. Spagnolo, Ruth E. Tenenbaum +3 more

Mindfulness Training vs Recovery Support for Opioid Use, Craving, and Anxiety During Buprenorphine Treatment

JAMA Network Open(2025)10.1001/jamanetworkopen.2024.54950

N/A

0.525DataRank · unranked

19 citations

Hannah J. Goodman, Joseph A. Rosansky, Alaine Kiera Fredericksen, Javier Barría-González, Gareth Parry +5 more

Transitioning off methadone: A qualitative study exploring why patients discontinue methadone treatment for opioid use disorder

Journal of Substance Use and Addiction Treatment(2023)10.1016/j.josat.2023.209055

N/A

0.483DataRank · unranked

24 citations

Jarratt D. Pytell, Kenneth B. Stoller, Vickie Walters, Roger D. Weiss, Geetanjali Chander +1 more

Long-term naturalistic follow-up of chronic pain in adults with prescription opioid use disorder

Drug and Alcohol Dependence(2019)10.1016/j.drugalcdep.2019.107675

N/A

0.396DataRank · unranked

13 citations

Margaret L. Griffin, R. Kathryn McHugh, Garrett M. Fitzmaurice, Robert N. Jamison, Scott E. Provost +2 more

Measuring principal substance of abuse in comorbid patients for clinical research

Addictive Behaviors(2009)10.1016/j.addbeh.2009.03.002

N/A

0.373DataRank · unranked

11 citations

Monika E. Kolodziej, Roger D. Weiss, Margaret L. Griffin

Effect of the Communities that HEAL intervention on receipt of behavioral therapies for opioid use disorder: A cluster randomized wait-list controlled trial

Drug and Alcohol Dependence(2024)10.1016/j.drugalcdep.2024.111286

N/A

0.249DataRank · unranked

4 citations

Christian Douglas, Joel G. Sprunger, Aimee Campbell, Redonna Chandler, Anindita Dasgupta +37 more

Modulating mechanisms of adverse childhood experiences in a mindfulness-based intervention: preliminary insights from an opioid use disorder study

Frontiers in Psychology(2025)10.3389/fpsyg.2025.1529106

N/A

0.104DataRank · unranked

1 citations

Joseph A. Rosansky, Paula Gardiner, Robert R. Edwards, Roger D. Weiss, Vitaly Napadow +2 more

Comparing the Performance of World Mental Health Composite International Diagnostic Interview Substance Abuse Module in Adolescents to Diagnoses Made by Pediatric Addiction Medicine Specialists

Journal of Addiction Medicine(2024)10.1097/adm.0000000000001271

N/A

0.104DataRank · unranked

1 citations

Machiko Minegishi, Melissa Brogna, Geetha Subramaniam, Jennifer McCormack, Roger D. Weiss +2 more

Effects of live-online, group mindfulness training on opioid use and anxiety during buprenorphine treatment: A comparative effectiveness RCT

Contemporary Clinical Trials(2023)10.1016/j.cct.2023.107417

N/A

0DataRank · unranked

3 citations

Leah Howard, Hannah J. Goodman, Kayley Okst, Thomas Fatkin, Alaine Kiera Fredericksen +7 more

Multiple Imputation for Non-Monotone Missing Not at Random Binary Data using the No Self-Censoring Model

arXiv (Cornell University)(2023)10.48550/arxiv.2302.12894

N/A

0DataRank · unranked

0 citations

Stuart R. Lipsitz, Roger D. Weiss, Garrett M. Fitzmaurice, Boyu Ren

A Research Agenda for Advancing Strategies to Improve Opioid Safety: Findings from a VHA State of the Art Conference

Journal of General Internal Medicine(2020)10.1007/s11606-020-06260-9

N/A

0DataRank · unranked

21 citations

Erin E. Krebs, Sara N. Edmond, Lewei Lin, Mark D. Sullivan, Roger D. Weiss +2 more

Toward AI-driven neuroepigenetic imaging biomarker for alcohol use disorder: A proof-of-concept study

iScience(2024)10.1016/j.isci.2024.110159

N/A

0DataRank · unranked

5 citations

Chieh-En Jane Tseng, Chi‐Hyeon Yoo, Meena M. Makary, Anna E. Goodheart, Robin Striar +21 more

Protocol for harmonization of randomized trials testing the addition of behavioral therapy to buprenorphine for opioid use disorder

Drug and Alcohol Dependence Reports(2024)10.1016/j.dadr.2024.100226

N/A

0DataRank · unranked

3 citations

Allen J. Bailey, Roger D. Weiss, Garrett M. Fitzmaurice, R. Kathryn McHugh

Primary Care Patients With Opioid Use Disorder Symptoms: Initiation and Engagement in Treatment With Medicine

The Annals of Family Medicine(2025)10.1370/afm.240440

N/A

0DataRank · unranked

1 citations

Theresa E. Matson, Malia Oliver, Kevin A. Hallgren, Roger D. Weiss, Katharine A. Bradley +1 more

Substance Use in Early Psychosis: Mixed Methods Impact on Family

Journal of Dual Diagnosis(2025)10.1080/15504263.2025.2557193

N/A

0DataRank · unranked

1 citations

Cheryl Yunn Shee Foo, Megan Liew, Edoardo N. Bianchi, Eleanor Sultana, Roger D. Weiss +2 more

Stigma and knowledge about medications for alcohol use disorder among treatment-seeking adults

Journal of Substance Use and Addiction Treatment(2025)10.1016/j.josat.2025.209831

N/A

0DataRank · unranked

0 citations

Mia A. Haidamus, Victoria R. Votaw, Gerardo González, Roger D. Weiss, Margaret L. Griffin +2 more

Cognitive behavioral therapy for anxiety and opioid use disorder: Development and pilot testing

Journal of Substance Use and Addiction Treatment(2024)10.1016/j.josat.2024.209296

N/A

0DataRank · unranked

3 citations

Garrett M. Fitzmaurice, Victoria R. Votaw, Rachel B. Geyer, Kael Ragnini, Shelly F. Greenfield +2 more

Depression history as a predictor of outcomes during buprenorphine-naloxone treatment of prescription opioid use disorder

Drug and Alcohol Dependence(2020)10.1016/j.drugalcdep.2020.108122

N/A

0DataRank · unranked

18 citations

Margaret L. Griffin, R. Kathryn McHugh, Roger D. Weiss, Andrew Peckham

Pain interference and catastrophizing are not associated with polysubstance use among treatment-seeking patients with substance use disorders and chronic pain

The American Journal of Drug and Alcohol Abuse(2020)10.1080/00952990.2020.1757687

N/A

0DataRank · unranked

9 citations

Katie Witkiewitz, Kevin E. Vowles, Roger D. Weiss, Margaret L. Griffin, R. Kathryn McHugh +1 more

Within-treatment frequency of use versus abstinence as a predictor of longitudinal post-treatment follow-up assessments of drug use

Drug and Alcohol Dependence(2020)10.1016/j.drugalcdep.2020.107857

N/A

0DataRank · unranked

8 citations

Stuart R. Lipsitz, Roger D. Weiss, Garrett M. Fitzmaurice

Pilot development and feasibility of telehealth Community Reinforcement and Family Training (CRAFT) for early psychosis and substance use

Psychiatry Research(2022)10.1016/j.psychres.2022.114804

N/A

0DataRank · unranked

23 citations

Andrea J. Wood, Mary Grace Shinners, Hadley Heinrich, Roger D. Weiss, Kim T. Mueser +5 more

Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder

JAMA Psychiatry(2022)10.1001/jamapsychiatry.2022.4020

N/A

0DataRank · unranked

22 citations

Bethea A. Kleykamp, Sandra D. Comer, Roland R. Griffiths, Andrew S. Huhn, Matthew W. Johnson +22 more

Association of Household Opioid Availability With Opioid Overdose

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.3385

N/A

0DataRank · unranked

18 citations

Sanae El Ibrahimi, Grant A. Ritter, Diana P. Flores, Michael A. Fischer, Roger D. Weiss +3 more

Methods for handling missing binary data in substance use disorder trials

Drug and Alcohol Dependence(2023)10.1016/j.drugalcdep.2023.110897

N/A

0DataRank · unranked

4 citations

Stuart R. Lipsitz, Roger D. Weiss, Garrett M. Fitzmaurice, Boyu Ren

Multiple imputation for non-monotone missing not at random data using the no self-censoring model

Statistical Methods in Medical Research(2023)10.1177/09622802231188520

N/A

0DataRank · unranked

3 citations

Stuart R. Lipsitz, Roger D. Weiss, Garrett M. Fitzmaurice, Boyu Ren

Roger D. Weiss

Indexed papers

Top data-sharing exemplar

Papers